Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Sunhawk Vision Biotech, Inc., explained in plain language.
This study is testing whether a new eye drop called SHJ002 can safely slow down the progression of nearsightedness in children aged 3 to 12. It will compare SHJ002 to atropine, a medication already used for this purpose. Researchers will measure changes in the children's eyeglass…
Phase: PHASE2 • Sponsor: Sunhawk Vision Biotech, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC